Industry Headwinds Slam Quarterly Results

Average Annualized Return Per Closed Trade: 32.4%
Average Return Per Closed Trade: 21.0%
Average Holding Period: 248 days

Lindsay Corporation (LNN) reported a disappointing fiscal second quarter and the shares dropped sharply into the mid-$70s. Revenues of $141 million missed by $15 million while earnings of 75 cents per share significantly missed by 38 cents and operating margins fell by more than 3 percentage points to 10.3 percent. Read more about Industry Headwinds Slam Quarterly Results

Dovish as Can Be 03-20-15

Last issue, we discussed this week's Federal Open Market Committee policy-setting meeting. We went against the grain and predicted Janet Yellen and her lieutenants would decide to keep the term "patient" in the policy statement. Contrary to our expectation, on Wednesday the Fed dropped that pledge. But investors need not fear that the end of an accommodative monetary policy is near. Rather, besides dropping that one over-analyzed word from the statement, everything else suggests that the Fed is even more dovish than before. Read more about Dovish as Can Be 03-20-15

The “Patient” Wait 03-13-15

Average Annualized Return Per Closed Trade: 32.4%
Average Return Per Closed Trade: 21.0%
Average Holding Period: 248 days

The FOMC will convene again for their regularly scheduled policy-setting meeting next week, announcing their decision on Wednesday afternoon. While there’s no chance of Janet Yellen and company raising interest rates at this meeting, market participants eagerly await to see whether the FOMC will keep the term “patient” in its policy statement. Read more about The “Patient” Wait 03-13-15

Acquisition News Boosts Our Biotech Stock 03-07-15

Average Annualized Return Per Closed Trade: 32.4%
Average Return Per Closed Trade: 21.0%
Average Holding Period: 248 days
Read more about Acquisition News Boosts Our Biotech Stock 03-07-15

A Turnaround Story and Surging Drug Sales 02-27-15

Average Annualized Return Per Closed Trade: 31.2%
Average Return Per Closed Trade: 20.2%
Average Holding Period: 247 days
Read more about A Turnaround Story and Surging Drug Sales 02-27-15

Good News Comes in Three 02-20-15

Average Annualized Return Per Closed Trade: 31.2%
Average Return Per Closed Trade: 20.2%
Average Holding Period: 247 days

It’s been a solid week for Brain Trust Profits. As of yesterday’s close, in essentially a breakeven week for the broad market, our stocks gained 2.3 percent on average. The strong performance is primarily driven by three surging stocks, which we will review below. Read more about Good News Comes in Three 02-20-15

Pages